{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T23:01:03Z","timestamp":1794524463713,"version":"4.9.1"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017003","name":"Peking University Health Science Center","doi-asserted-by":"publisher","award":["BMU2021PY010"],"award-info":[{"award-number":["BMU2021PY010"]}],"id":[{"id":"10.13039\/501100017003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002461"],"award-info":[{"award-number":["82002461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijbiomac.2025.144837","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T18:02:03Z","timestamp":1748800923000},"page":"144837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Effect of histone deacetylases on pancreatic physiology and pathology: a review"],"prefix":"10.1016","volume":"318","author":[{"given":"Xinran","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ijbiomac.2025.144837_bb0005","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1111\/bph.13984","article-title":"Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia","volume":"174","author":"Bombardo","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144837_bb0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pan.2012.02.013","article-title":"HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA)","volume":"12","author":"Mehdi","year":"2012","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144837_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/pharmrev.122.000612","article-title":"Pharmacological modulation of the crosstalk between aberrant Janus kinase signaling and epigenetic modifiers of the histone deacetylase family to treat cancer","volume":"75","author":"Mustafa","year":"2023","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144837_bb0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.2022050598","article-title":"Cell cycle and senescence regulation by podocyte histone deacetylase 1 and 2","volume":"34","author":"Rangel","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144837_bb0025","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI124030","article-title":"Podocyte histone deacetylase activity regulates murine and human glomerular diseases","volume":"129","author":"Inoue","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144837_bb0030","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S1097-2765(02)00702-5","article-title":"Histone acetylation regulates the time of replication origin firing","volume":"10","author":"Vogelauer","year":"2002","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144837_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molcel.2008.02.030","article-title":"Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control","volume":"30","author":"Bhaskara","year":"2008","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144837_bb0040","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1158\/0008-5472.CAN-09-3028","article-title":"Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage","volume":"70","author":"Conti","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144837_bb0045","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41467-018-03096-0","article-title":"HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130","volume":"9","author":"G\u00f6der","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00432-019-03118-4","article-title":"Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes","volume":"146","author":"Kiweler","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jare.2023.07.005","article-title":"Novel hydroxamic acid derivative induces apoptosis and constrains autophagy in leukemic cells","volume":"60","author":"Fischer","year":"2024","journal-title":"J. Adv. Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144837_bb0060","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1158\/0008-5472.CAN-15-2680","article-title":"Enhanced histone deacetylase activity in malignant melanoma provokes RAD51 and FANCD2-triggered drug resistance","volume":"76","author":"Krumm","year":"2016","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144837_bb0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cac2.12280","article-title":"Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition","volume":"42","author":"Schneeweis","year":"2022","journal-title":"Cancer Commun."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.144837_bb0070","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.3390\/cancers15143650","article-title":"NOXA accentuates apoptosis induction by a novel histone deacetylase inhibitor","volume":"15","author":"Ashry","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cellsig.2016.11.002","article-title":"Class I histone deacetylases regulate p53\/NF-\u03baB crosstalk in cancer cells","volume":"29","author":"Sch\u00e4fer","year":"2017","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144837_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18485","article-title":"HDAC inhibitor attenuates rat traumatic brain injury induced neurological impairments","volume":"9","author":"Lu","year":"2023","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144837_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14646","article-title":"Attenuation of neuronal ferroptosis in intracerebral hemorrhage by inhibiting HDAC1\/2: microglial heterogenization via the Nrf2\/HO1 pathway","volume":"30","author":"Jiang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144837_bb0090","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1038\/ncomms7200","article-title":"Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia","volume":"6","author":"Liou","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144837_bb0095","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","article-title":"The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon","volume":"13","author":"Donohoe","year":"2011","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144837_bb0100","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"7478","key":"10.1016\/j.ijbiomac.2025.144837_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature12687","article-title":"Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis","volume":"504","author":"Alenghat","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144837_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","article-title":"Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis","volume":"40","author":"Singh","year":"2014","journal-title":"Immunity"},{"issue":"7480","key":"10.1016\/j.ijbiomac.2025.144837_bb0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"issue":"7480","key":"10.1016\/j.ijbiomac.2025.144837_bb0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144837_bb0125","doi-asserted-by":"crossref","first-page":"2485S","DOI":"10.1093\/jn\/133.7.2485S","article-title":"Inhibition of histone deacetylase activity by butyrate","volume":"133","author":"Davie","year":"2003","journal-title":"J. Nutr."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144837_bb0130","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm.2744","article-title":"Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration","volume":"18","author":"Sun","year":"2012","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144837_bb0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2011.03.043","article-title":"Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis","volume":"145","author":"Mihaylova","year":"2011","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144837_bb0140","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/emboj.2008.51","article-title":"Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks","volume":"27","author":"Knutson","year":"2008","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144837_bb0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144837_bb0150","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144837_bb0155","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.144837_bb0160","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.1073\/pnas.0708100105","article-title":"Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy","volume":"105","author":"Raffaghello","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1335246","article-title":"Epigenetic small-molecule screen for inhibition and reversal of acinar ductal metaplasia in mouse pancreatic organoids","volume":"15","author":"Atanasova","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144837_bb0170","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1158\/0008-5472.CAN-12-3359","article-title":"Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer","volume":"73","author":"Wauters","year":"2013","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144837_bb0175","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1016\/j.ajpath.2015.08.006","article-title":"Valproic acid limits pancreatic recovery after pancreatitis by inhibiting histone deacetylases and preventing acinar redifferentiation programs","volume":"185","author":"Eisses","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144837_bb0180","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41420-022-01165-4","article-title":"Pharmacological inhibition and reversal of pancreatic acinar ductal metaplasia","volume":"8","author":"da Silva","year":"2022","journal-title":"Cell Death Dis."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.144837_bb0185","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.3390\/cancers13174389","article-title":"Cyclin dependent kinase-1 (CDK-1) inhibition as a novel therapeutic strategy against pancreatic ductal adenocarcinoma (PDAC)","volume":"13","author":"Wijnen","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biopha.2015.08.017","article-title":"Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1\/Cdk1 in pancreatic cancer cells","volume":"74","author":"Feng","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144837_bb0195","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mc.22024","article-title":"Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo","volume":"53","author":"Chien","year":"2014","journal-title":"Mol. Carcinog."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144837_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075102","article-title":"The anti-tumor effect of HDAC inhibition in a human pancreas cancer model is significantly improved by the simultaneous inhibition of cyclooxygenase 2","volume":"8","author":"Peulen","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144837_bb0205","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3892\/ijo.2014.2568","article-title":"Histone deacetylase 3 promotes pancreatic cancer cell proliferation, invasion and increases drug-resistance through histone modification of P27, P53 and Bax","volume":"45","author":"Jiao","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.144837_bb0210","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.8654","article-title":"Yin Yang-1 increases apoptosis through Bax activation in pancreatic cancer cells","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144837_bb0215","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1158\/1535-7163.MCT-04-0186","article-title":"Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines","volume":"4","author":"Garc\u00eda Morales","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144837_bb0220","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbamcr.2007.05.002","article-title":"Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine","volume":"1773","author":"Donadelli","year":"2007","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144837_bb0225","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1158\/0008-5472.CAN-10-3289","article-title":"Deciphering the molecular events necessary for synergistic tumor cell apoptosis mediated by the histone deacetylase inhibitor vorinostat and the BH3 mimetic ABT-737","volume":"71","author":"Wiegmans","year":"2011","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144837_bb0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbamcr.2004.07.001","article-title":"Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro-and anti-apoptotic genes in pancreatic adenocarcinoma cells","volume":"1693","author":"Moore","year":"2004","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-019-0681-6","article-title":"Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status","volume":"11","author":"Chao","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144837_bb0240","article-title":"A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144837_bb0245","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbrc.2006.07.185","article-title":"Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells","volume":"348","author":"Bai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144837_bb0250","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3390\/cells10102520","article-title":"Class 1 histone deacetylases and ataxia-telangiectasia mutated kinase control the survival of murine pancreatic cancer cells upon dNTP depletion","volume":"10","author":"Nguyen","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144837_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010376","article-title":"c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589","volume":"5","author":"Kauh","year":"2010","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.144837_bb0260","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-9-80","article-title":"HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells","volume":"9","author":"Sch\u00fcler","year":"2010","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144837_bb0270","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2105691119","article-title":"NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer","volume":"119","author":"Doffo","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0275","first-page":"1","article-title":"Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt\/mTOR signaling","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144837_bb0280","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.freeradbiomed.2012.09.019","article-title":"In vivo redox state of human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)","volume":"53","author":"Ungerstedt","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144837_bb0285","first-page":"2402","article-title":"Antitumor activity of the novel HDAC inhibitor CUDC-101 combined with gemcitabine in pancreatic cancer","volume":"8","author":"Ji","year":"2018","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144837_bb0290","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/ab157a","article-title":"Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention","volume":"16","author":"Antony","year":"2019","journal-title":"Phys. Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144837_bb0295","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","article-title":"Contextual determinants of TGF\u03b2 action in development, immunity and cancer","volume":"19","author":"David","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144837_bb0300","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/0008-5472.CAN-20-3209","article-title":"HDAC2 facilitates pancreatic cancer metastasis","volume":"82","author":"Krau\u00df","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-08388-1","article-title":"Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition","volume":"21","author":"Ramaker","year":"2021","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144837_bb0310","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/cas.13700","article-title":"Role of histone deacetylase 1 in distant metastasis of pancreatic ductal cancer","volume":"109","author":"Shinke","year":"2018","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144837_bb0315","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.canlet.2014.02.012","article-title":"Therapeutic potential of histone deacetylase inhibitors in pancreatic cancer","volume":"347","author":"Feng","year":"2014","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144837_bb0320","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mc.21961","article-title":"Involvement of annexin A8 in the properties of pancreatic cancer","volume":"53","author":"Hata","year":"2014","journal-title":"Mol. Carcinog."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144837_bb0325","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1053\/j.gastro.2011.04.025","article-title":"Which way to die: the regulation of acinar cell death in pancreatitis by mitochondria, calcium, and reactive oxygen species","volume":"140","author":"Gukovskaya","year":"2011","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144837_bb0330","doi-asserted-by":"crossref","first-page":"21988","DOI":"10.1002\/jcp.28761","article-title":"Restoration of p53 acetylation by HDAC inhibition permits the necrosis\/apoptosis switch of pancreatic ainar cell during experimental pancreatitis in mice","volume":"234","author":"Hu","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144837_bb0335","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/hmg\/ddab370","article-title":"The anti-inflammatory mechanism of SAHA in acute pancreatitis through HDAC5\/SLIT2\/Akt\/\u03b2-catenin axis","volume":"31","author":"Tong","year":"2022","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144837_bb0340","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10620-014-3474-y","article-title":"Histone deacetylase regulates trypsin activation, inflammation, and tissue damage in acute pancreatitis in mice","volume":"60","author":"Hartman Magnusson","year":"2015","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144837_bb0345","first-page":"56","article-title":"Matrix turnover in fibrogenesis","volume":"43","author":"Iredale","year":"1996","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144837_bb0350","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1124\/mol.117.110924","article-title":"Inhibition of class i histone deacetylases abrogates tumor growth factor \u03b2 expression and development of fibrosis during chronic pancreatitis","volume":"94","author":"Bombardo","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0355","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s13577-020-00387-x","article-title":"HDAC inhibitors promote pancreatic stellate cell apoptosis and relieve pancreatic fibrosis by upregulating miR-15\/16 in chronic pancreatitis","volume":"33","author":"Ji","year":"2020","journal-title":"Hum. Cell"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144837_bb0360","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.bbadis.2016.06.017","article-title":"Cerulein-induced pancreatic fibrosis is modulated by Smad7, the major negative regulator of transforming growth factor-\u03b2 signaling","volume":"1862","author":"Li","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144837_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107231","article-title":"Pharmacological HDAC inhibition impairs pancreatic \u03b2-cell function through an epigenome-wide reprogramming","volume":"26","author":"Oger","year":"2023","journal-title":"Iscience"},{"issue":"36","key":"10.1016\/j.ijbiomac.2025.144837_bb0370","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11295","article-title":"Conditional ablation of HDAC3 in islet beta cells results in glucose intolerance and enhanced susceptibility to STZ-induced diabetes","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0375","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00592-018-1201-4","article-title":"MC1568 improves insulin secretion in islets from type 2 diabetes patients and rescues \u03b2-cell dysfunction caused by Hdac7 upregulation","volume":"55","author":"Daneshpajooh","year":"2018","journal-title":"Acta Diabetol."},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.144837_bb0380","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1128\/MCB.00413-08","article-title":"Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors","volume":"28","author":"Haumaitre","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144837_bb0385","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.3390\/cells10113249","article-title":"Butyrate and class I histone deacetylase inhibitors promote differentiation of neonatal porcine islet cells into beta cells","volume":"10","author":"Zhang","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13577-019-00292-y","article-title":"Exploring the effect of epigenetic modifiers on developing insulin-secreting cells","volume":"33","author":"Elsharkawi","year":"2020","journal-title":"Hum. Cell"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144837_bb0395","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.2337\/db11-0440","article-title":"Specific control of pancreatic endocrine \u03b2-and \u03b4-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9","volume":"60","author":"Lenoir","year":"2011","journal-title":"Diabetes"},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.144837_bb0400","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1042\/BCJ20180465","article-title":"HDAC1 overexpression enhances \u03b2-cell proliferation by down-regulating Cdkn1b\/p27","volume":"475","author":"Draney","year":"2018","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144837_bb0405","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3390\/cells10061408","article-title":"Targeting HDACs in pancreatic neuroendocrine tumor models","volume":"10","author":"Schmitz","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144837_bb0410","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.chembiol.2012.05.010","article-title":"Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis","volume":"19","author":"Chou","year":"2012","journal-title":"Chem. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144837_bb0415","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1021\/acschembio.5b00640","article-title":"An isochemogenic set of inhibitors to define the therapeutic potential of histone deacetylases in \u03b2-cell protection","volume":"11","author":"Wagner","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0420","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2119\/molmed.2010.00152","article-title":"The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet \u03b2 cells in vivo and in vitro","volume":"17","author":"Lewis","year":"2011","journal-title":"Mol. Med."},{"issue":"43","key":"10.1016\/j.ijbiomac.2025.144837_bb0425","doi-asserted-by":"crossref","first-page":"17598","DOI":"10.1074\/jbc.M117.804328","article-title":"Isoform-selective inhibitor of histone deacetylase 3 (HDAC3) limits pancreatic islet infiltration and protects female nonobese diabetic mice from diabetes","volume":"292","author":"Dirice","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.144837_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413330","article-title":"The HDAC inhibitor butyrate impairs \u03b2 cell function and activates the disallowed gene hexokinase I","volume":"22","author":"Bridgeman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2014.02.001","article-title":"Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38\/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat","volume":"213","author":"Khan","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0440","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11684-018-0646-8","article-title":"Intracellular and extracellular TGF-\u03b2 signaling in cancer: some recent topics","volume":"12","author":"Miyazono","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109753","article-title":"Pan-HDAC inhibitors augment IL2-induced proliferation of NK cells via the JAK2-STAT5B signaling pathway","volume":"116","author":"Zheng","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.628453","article-title":"Butyrate shapes immune cell fate and function in allergic asthma","volume":"12","author":"Yip","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144837_bb0455","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.3390\/ijms20092241","article-title":"Immunoepigenetics combination therapies: an overview of the role of HDACs in cancer immunotherapy","volume":"20","author":"Banik","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.144837_bb0460","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.3390\/cancers14153709","article-title":"Histone deacetylase inhibitors restore cancer cell sensitivity towards T lymphocytes mediated cytotoxicity in pancreatic cancer","volume":"14","author":"Looi","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0465","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00428-020-02790-z","article-title":"Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified","volume":"477","author":"Kim","year":"2020","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144837_bb0470","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.pan.2019.01.011","article-title":"HDAC3 modulates cancer immunity via increasing PD-L1 expression in pancreatic cancer","volume":"19","author":"Hu","year":"2019","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144837_bb0475","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14728222.2018.1451514","article-title":"FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity","volume":"22","author":"Whiteside","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144837_bb0480","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1158\/2326-6066.CIR-18-0070","article-title":"Entinostat converts immune-resistant breast and pancreatic cancers into checkpoint-responsive tumors by reprogramming tumor-infiltrating MDSCs","volume":"6","author":"Christmas","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144837_bb0485","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-051X.2005.00658.x","article-title":"The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus","volume":"32","author":"K\u0131ran","year":"2005","journal-title":"J. Clin. Periodontol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.144837_bb0490","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2007.01.013","article-title":"Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system","volume":"18","author":"Zwirner","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-370","article-title":"Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K\/Akt signaling pathway","volume":"14","author":"Shi","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144837_bb0500","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/15384047.2018.1507258","article-title":"Prior exposure of pancreatic tumors to [sorafenib+ vorinostat] enhances the efficacy of an anti-PD-1 antibody","volume":"20","author":"Booth","year":"2019","journal-title":"Cancer Biol. Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144837_bb0505","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.18632\/oncotarget.6820","article-title":"HDAC3 mediates smoking-induced pancreatic cancer","volume":"7","author":"Edderkaoui","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0510","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00432-015-2026-y","article-title":"Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab-and chemo-resistant lymphoma cells to chemotherapy agents","volume":"142","author":"Xue","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.144837_bb0515","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/md17070384","article-title":"Marine-derived natural lead compound disulfide-linked dimer psammaplin A: biological activity and structural modification","volume":"17","author":"Jing","year":"2019","journal-title":"Mar. Drugs"},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.144837_bb0520","first-page":"4916","article-title":"FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases","volume":"62","author":"Furumai","year":"2002","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144837_bb0525","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/cncr.31817","article-title":"Mocetinostat for patients with previously treated, locally advanced\/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes","volume":"125","author":"Grivas","year":"2019","journal-title":"Cancer"},{"issue":"15_suppl","key":"10.1016\/j.ijbiomac.2025.144837_bb0530","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.2020.38.15_suppl.1014","article-title":"Results of ENCORE 602 (TRIO025), a phase II, randomized, placebo-controlled, double-blinded, multicenter study of atezolizumab with or without entinostat in patients with advanced triple-negative breast cancer (aTNBC)","volume":"38","author":"O'Shaughnessy","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144837_bb0535","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41385-019-0135-7","article-title":"HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGF\u03b21 signalling in inflammation","volume":"12","author":"Friedrich","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144837_bb0540","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/febs.15456","article-title":"HDAC11 is a novel regulator of fatty acid oxidative metabolism in skeletal muscle","volume":"288","author":"Hurtado","year":"2021","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144837_bb0545","first-page":"1401","article-title":"Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells","volume":"94","author":"Byrd","year":"1999","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144837_bb0550","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.3390\/cancers12123748","article-title":"Dual pharmacological targeting of HDACs and PDE5 inhibits liver disease progression in a mouse model of biliary inflammation and fibrosis","volume":"12","author":"Claveria Cabello","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0555","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2020.00085","article-title":"The multidisciplinary team (MDT) approach and quality of care","volume":"10","author":"Taberna","year":"2020","journal-title":"Front. Oncol."},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.144837_bb0560","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.4538","article-title":"A MEK\/PI3K\/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells","volume":"6","author":"Ischenko","year":"2015","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.144837_bb0565","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.3390\/molecules25225407","article-title":"A G-Quadruplex-binding small molecule and the HDAC inhibitor SAHA (Vorinostat) act synergistically in gemcitabine-sensitive and resistant pancreatic cancer cells","volume":"25","author":"Ahmed","year":"2020","journal-title":"Molecules"},{"issue":"25","key":"10.1016\/j.ijbiomac.2025.144837_bb0570","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0575","doi-asserted-by":"crossref","first-page":"9015","DOI":"10.1007\/s13277-015-3537-5","article-title":"Targeting pancreatic cancer cells by a novel hydroxamate-based histone deacetylase (HDAC) inhibitor ST-3595","volume":"36","author":"Minjie","year":"2015","journal-title":"Tumour Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144837_bb0580","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/biomedicines10030517","article-title":"The Class I HDAC inhibitor valproic acid strongly potentiates gemcitabine efficacy in pancreatic cancer by immune system activation","volume":"10","author":"Blaauboer","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0585","first-page":"246","article-title":"HDAC inhibitors, MS-275 and salermide, potentiates the anticancer effect of EF24 in human pancreatic cancer cells","volume":"15","author":"Saglam","year":"2016","journal-title":"EXCLI J."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0590","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10637-018-0634-5","article-title":"Phase I study of resminostat, an HDAC inhibitor, combined with S-1 in patients with pre-treated biliary tract or pancreatic cancer","volume":"37","author":"Ikeda","year":"2019","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0595","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1007\/s13277-015-4216-2","article-title":"SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin","volume":"37","author":"Park","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0600","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fonc.2019.01534","article-title":"ErbB2 targeted epigenetic modulation: anti-tumor efficacy of the ADC trastuzumab-HDACi ST8176AA1","volume":"9","author":"Milazzo","year":"2020","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144837_bb0605","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41368-019-0053-2","article-title":"Harnessing the HDAC\u2013histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering","volume":"11","author":"Lawlor","year":"2019","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0610","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ejmech.2014.09.024","article-title":"Design, synthesis, and biological evaluation of 1, 3-disubstituted-pyrazole derivatives as new class I and IIb histone deacetylase inhibitors","volume":"86","author":"Yao","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.144837_bb0615","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3390\/cancers16152713","article-title":"Synergistic efficacy of CDK4\/6 inhibitor abemaciclib and HDAC inhibitor panobinostat in pancreatic cancer cells","volume":"16","author":"Bhutkar","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144837_bb0620","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.18632\/oncotarget.724","article-title":"Superior efficacy of co-treatment with dual PI3K\/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer","volume":"3","author":"Venkannagari","year":"2012","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144837_bb0625","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7150\/thno.40195","article-title":"Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression","volume":"10","author":"Kim","year":"2020","journal-title":"Theranostics"},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.144837_bb0630","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.4161\/cbt.8.14.8633","article-title":"Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer","volume":"8","author":"Chun","year":"2009","journal-title":"Cancer Biol. Ther."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144837_bb0635","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/nm.3952","article-title":"Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma","volume":"21","author":"Mazur","year":"2015","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144837_bb0640","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/cancers11091327","article-title":"Selective inhibition of histone deacetylases 1\/2\/6 in combination with gemcitabine: a promising combination for pancreatic cancer therapy","volume":"11","author":"Laschanzky","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.144837_bb0645","article-title":"Combined HDAC and eIF4A inhibition: a novel epigenetic therapy for pancreatic adenocarcinoma","author":"Safari","year":"2024","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.144837_bb0650","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/v14051006","article-title":"HDAC inhibitors enhance efficacy of the oncolytic adenoviruses Ad\u2206\u2206 and Ad-3\u2206-A20T in pancreatic and triple-negative breast cancer models","volume":"14","author":"Rodr\u00edguez","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144837_bb0655","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1038\/s41467-024-52528-7","article-title":"Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial","volume":"15","author":"Baretti","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144837_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2023.194941","article-title":"Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via deacetylation of the HRD1-SEL1L complex","volume":"1866","author":"Ping","year":"2023","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144837_bb0665","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00180810","article-title":"Preclinical antitumor activity of CI-994","volume":"14","author":"LoRusso","year":"1996","journal-title":"Investig. New Drugs"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144837_bb0670","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1081\/CNV-200039852","article-title":"Phase I study of oral CI-994 in combination with carboplatin and paclitaxel in the treatment of patients with advanced solid tumors","volume":"22","author":"Pauer","year":"2004","journal-title":"Cancer Investig."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144837_bb0675","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/cancers11091327","article-title":"Selective inhibition of histone deacetylases 1\/2\/6 in combination with gemcitabine: a promising combination for pancreatic cancer therapy","volume":"11","author":"Laschanzky","year":"2019","journal-title":"Cancers (Basel)"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025053899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025053899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:22:47Z","timestamp":1762240967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025053899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":135,"alternative-id":["S0141813025053899"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144837","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of histone deacetylases on pancreatic physiology and pathology: a review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"144837"}}